Trevi Therapeutics, Inc.
TRVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563880
In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in Trevi Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 154
- +17 vs. Q1 2025
- Shares held
- 114.7M
- +26.5M (+30.1%) vs. Q1 2025
- Total value
- $627.2M
- +$72.8M (+13.1%) vs. Q1 2025
- New holders
- 40
- 65 more added
- Sold out
- 23
- 31 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 218 | $2.76B |
| Q1 2026 | 198 | $1.61B |
| Q4 2025 | 184 | $1.63B |
| Q3 2025 | 164 | $1.18B |
| Q2 2025 | 154 | $627.2M |
| Q1 2025 | 137 | $554.3M |
| Q4 2024 | 110 | $329.5M |
| Q3 2024 | 93 | $194.1M |
| Q2 2024 | 77 | $166.6M |
| Q1 2024 | 80 | $177.9M |
| Q4 2023 | 63 | $70.0M |
| Q3 2023 | 55 | $106.1M |
| Q2 2023 | 53 | $116.7M |
| Q1 2023 | 36 | $80.4M |
| Q4 2022 | 37 | $83.3M |
| Q3 2022 | 40 | $70.5M |
| Q2 2022 | 32 | $80.8M |
| Q1 2022 | 23 | $32.9M |
| Q4 2021 | 17 | $10.3M |
| Q3 2021 | 18 | $17.4M |
| Q2 2021 | 17 | $28.1M |
| Q1 2021 | 19 | $35.6M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Trevi Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wellington Management Group LLP | 171,982 | $940.7K | 0.00% | +44,530+34.9% | Added |
| Diadema Partners LP | 185,830 | $1.02M | 0.63% | +5,830+3.2% | Added |
| Charles Schwab Investment Management Inc | 225,935 | $1.24M | 0.00% | +18,417+8.9% | Added |
| Prudential Financial Inc | 226,381 | $1.24M | 0.00% | +226,381 | New |
| Goldman Sachs Group Inc | 299,045 | $1.64M | 0.00% | +87,172+41.1% | Added |
| Rosalind Advisors, Inc. | 300,000 | $1.64M | 0.79% | −312,901−51.1% | Reduced |
| Invesco Ltd. | 322,339 | $1.76M | 0.00% | −530,646−62.2% | Reduced |
| Tejara Capital Ltd | 326,395 | $1.79M | 0.83% | +146,879+81.8% | Added |
| UBS Group AG | 354,225 | $1.94M | 0.00% | +261,192+280.8% | Added |
| FMR LLC | 368,529 | $2.02M | 0.00% | +362,528+6,041.1% | Added |
| Opaleye Management Inc. | 390,000 | $2.13M | 0.43% | −405,000−50.9% | Reduced |
| Qube Research & Technologies Ltd | 447,852 | $2.45M | 0.00% | +321,623+254.8% | Added |
| EAM Investors, LLC | 486,624 | $2.66M | 0.40% | −64,295−11.7% | Reduced |
| Renaissance Technologies LLC | 489,300 | $2.68M | 0.00% | +400,400+450.4% | Added |
| Acuta Capital Partners, LLC | 493,735 | $2.70M | 3.77% | −292,226−37.2% | Reduced |
| Barclays PLC | 515,476 | $2.82M | 0.00% | +377,544+273.7% | Added |
| Burkehill Global Management, LP | 525,000 | $2.87M | 0.21% | +525,000 | New |
| Silverarc Capital Management, LLC | 539,587 | $2.95M | 0.60% | +9,587+1.8% | Added |
| Panagora Asset Management Inc | 569,702 | $3.12M | 0.01% | +229,798+67.6% | Added |
| Northern Trust Corp | 576,471 | $3.15M | 0.00% | +10,274+1.8% | Added |
| Alyeska Investment Group, L.P. | 650,000 | $3.56M | 0.01% | +650,000 | New |
| Soleus Capital Management, L.P. | 700,000 | $3.83M | 0.26% | +700,000 | New |
| Sphera Funds Management Ltd. | 799,957 | $4.38M | 1.14% | +799,957 | New |
| Royal Bank of Canada | 824,180 | $4.51M | 0.00% | +805,082+4,215.5% | Added |
| MAI Capital Management | 847,553 | $4.64M | 0.03% | −537,497−38.8% | Reduced |
| Logos Global Management LP | 850,000 | $4.65M | 0.62% | +425,285+100.1% | Added |
| J. Goldman & Co LP | 979,098 | $5.36M | 0.17% | +777,991+386.9% | Added |
| Morgan Stanley | 1,024,011 | $5.60M | 0.00% | +529,444+107.1% | Added |
| Raymond James Financial Inc | 1,076,683 | $5.89M | 0.00% | +567,304+111.4% | Added |
| Bank of America Corp | 1,097,497 | $6.00M | 0.00% | +965,732+732.9% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,146,110 | $6.27M | 3.89% | +1,146,110 | New |
| Artia Global Partners LP | 1,311,840 | $7.18M | 1.85% | +1,311,840 | New |
| Citadel Advisors LLC | 1,319,266 | $7.22M | 0.01% | +1,319,266 | New |
| Eventide Asset Management, LLC | 1,381,324 | $7.56M | 0.13% | +1,381,324 | New |
| Viking Global Investors LPSuperinvestorViking Global Investors | 1,543,000 | $8.44M | 0.02% | −1,684,792−52.2% | Reduced |
| Point72 Asset Management, L.P. | 1,728,676 | $9.46M | 0.02% | −639,329−27.0% | Reduced |
| Geode Capital Management, LLC | 1,786,845 | $9.78M | 0.00% | +171,980+10.6% | Added |
| State Street Corp | 1,832,920 | $10.0M | 0.00% | +408,414+28.7% | Added |
| Acorn Capital Advisors, LLC | 2,144,844 | $11.7M | 7.67% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 2,354,402 | $12.9M | 0.03% | +595,783+33.9% | Added |
| Marshall Wace, LLP | 2,477,916 | $13.6M | 0.02% | −76,305−3.0% | Reduced |
| Affinity Asset Advisors, LLC | 2,534,058 | $13.9M | 2.05% | +1,284,058+102.7% | Added |
| OrbiMed Advisors LLC | 3,308,400 | $18.1M | 0.46% | +2,188,400+195.4% | Added |
| MPM Oncology Impact Management LP | 3,406,955 | $18.6M | 3.23% | −21,411−0.6% | Reduced |
| Octagon Capital Advisors LP | 3,672,000 | $20.1M | 4.41% | +350,000+10.5% | Added |
| Siren, L.L.C. | 3,938,793 | $21.5M | 1.11% | +1,075,000+37.5% | Added |
| Woodline Partners LP | 4,046,435 | $22.1M | 0.12% | +1,988,623+96.6% | Added |
| Alliancebernstein L.P. | 4,281,355 | $23.4M | 0.01% | +4,259,015+19,064.5% | Added |
| Vivo Capital, LLC | 4,487,903 | $24.5M | 2.51% | +1,000,000+28.7% | Added |
| Vanguard Group Inc | 5,316,691 | $29.1M | 0.00% | +1,478,659+38.5% | Added |
| BlackRock, Inc. | 8,205,006 | $44.9M | 0.00% | +2,892,464+54.4% | Added |
| Rubric Capital Management LP | 8,531,860 | $46.7M | 0.75% | +3,993,325+88.0% | Added |
| Frazier Life Sciences Management, L.P. | 10,259,409 | $56.1M | 2.24% | 00.0% | Unchanged |
| NEA Management Company, LLC | 13,222,228 | $72.3M | 5.44% | +1,851,852+16.3% | Added |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −2,988,000−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −686,219−100.0% | Sold out |
| VR Adviser, LLC | 0 | $0 | 0.00% | −615,506−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −575,000−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −440,000−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −340,164−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −164,740−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −163,738−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −160,815−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −79,796−100.0% | Sold out |
| Braidwell LP | 0 | $0 | 0.00% | −72,083−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −58,679−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −49,937−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −36,503−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −24,661−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −23,996−100.0% | Sold out |
| CIBC World Markets Corp | 0 | $0 | 0.00% | −16,534−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −13,200−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,051−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −78−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −20−100.0% | Sold out |